These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E. J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143 [Abstract] [Full Text] [Related]
6. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, Alavi J, Reivich M. J Nucl Med; 1987 Nov; 28(11):1667-70. PubMed ID: 3499490 [Abstract] [Full Text] [Related]
7. High-resolution PET studies in Alzheimer's disease. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI. Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867 [Abstract] [Full Text] [Related]